首页> 美国卫生研究院文献>Immunology >The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.
【2h】

The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

机译:人CD59的绵羊类似物:其补体抑制活性的纯化和表征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An inhibitor of the membrane attack complex of complement was isolated from the membranes of sheep erythrocytes. Fast protein liquid chromatography (FPLC) and affinity purification procedures for this sheep complement-inhibiting protein (SCIP) both yielded a pure protein with an apparent M(r) of 19,000 under reducing and non-reducing conditions. Incubation of the denatured protein with neuraminidase and Endo-F reduced the apparent M(r) to 18,000 and 15,000 respectively, while treatment with O-deglycosidase or phosphatidylinositol-specific phospholipase C (PIPLC) did not affect the apparent M(r). SCIP was detectable on erythrocytes and lymphocytes but not on platelets and could partially be removed by PIPLC treatment. Deglycosylation of the pure protein markedly reduced and PIPLC treatment abolished its activity. A monoclonal antibody (mAb) raised against sheep complement-inhibiting protein (SCIP) enhanced the susceptibility of sheep erythrocytes to lysis by homologous complement. SCIP inhibited complement after the stage of C5b-7 formation. Amino-terminal protein sequence was obtained and was shown to be similar to that of human CD59. All these features suggest that SCIP is the sheep equivalent of human CD59. Human CD59 has been reported to be species selective in that it inhibits complement from relatively few species. However, SCIP efficiently inhibited lysis of guinea-pig erythrocytes by complement from a wide range of species tested indicating that it is a potent and non-selective inhibitor of the membrane attack complex of complement (MAC).
机译:从绵羊红细胞的膜中分离出补体的膜攻击复合物的抑制剂。快速蛋白质液相色谱(FPLC)和该绵羊补体抑制蛋白(SCIP)的亲和纯化程序在还原和非还原条件下均产生表观M(r)为19,000的纯蛋白。将变性蛋白与神经氨酸酶和Endo-F一起温育分别将表观M(r)降至18,000和15,000,而用O-去糖苷酶或磷脂酰肌醇特异性磷脂酶C(PIPLC)处理不会影响表观M(r)。在红细胞和淋巴细胞上可检测到SCIP,但在血小板上却检测不到,并且可以通过PIPLC处理部分清除。纯蛋白的去糖基化明显减少,PIPLC处理取消了其活性。抗绵羊补体抑制蛋白(SCIP)的单克隆抗体(mAb)增强了绵羊红细胞对同源补体裂解的敏感性。在C5b-7形成阶段之后,SCIP抑制补体。获得了氨基末端蛋白序列,并显示出与人CD59相似的序列。所有这些特征表明,SCIP相当于人类CD59的绵羊。据报道,人CD59具有物种选择性,因为它抑制了相对少数物种的补体。但是,SCIP可通过多种测试物种的补体有效抑制豚鼠红细胞的溶解,这表明它是补体(MAC)膜攻击复合物的有效且非选择性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号